News / Health

Common Form of Leukemia Could be Treatable With New Pill

Jessica Berman
An experimental pill could turn a lethal cancer into a chronic, but manageable disease like high blood pressure.  If approved for treatment for a common form of leukemia, the compound replaces toxic chemotherapy treatments.  

Chronic lymphocytic leukemia, or CLL, is a cancer of the immune system’s B cells, which produce antibodies, the frontline soldiers against bacterial and viral invaders.  But when B cells become cancerous, they accumulate in the patient’s organs, including the lymph nodes, pea-shaped organs under the arms and in the groin that help the body recognize and fight infections.  With CLL, the nodes swell many times their normal size.

Richard Furman, a cancer researcher at Weill Cornell Medical College in New York, says the drug idelalisib, taken twice a day, causes the cancer to melt away.

“When I say melt away, you can literally see the lymph nodes shrink over the course of a couple of days.  It works that quickly, which is really wonderful," said Furman.

The standard treatment for CLL is Rituxan,  an infusion drug that destroys diseased B cells, but only for a time before the patient relapses.  With repeated rounds of chemotherapy, Furman says the leukemia eventually becomes resistant to Rituxan and patients no longer respond.  The cancer is fatal.

Investigators led by Furman compared a combination of idelalisib and Rituxan, to Rituxan and placebo in a group of 220 CLL patients from around the world (19 medical centers in the U.S. and five other countries).

Six months into the study, 13 percent of those receiving only Rituxan responded to the therapy compared to 81 percent of the Idelalisib combination group.  

And 92 percent of participants in that group were still alive a year after the study began, compared to 80 percent in the Rituxan-only group.

The contrast was so significant that the study was halted early so all the patients could receive Idelalisib.

“And with an agent like idelalisib, which is extraordinarily well-tolerated and extraordinarily effective, my hope is that we can make CLL a chronic disease, sort of akin to high blood pressure where patients are able to take a pill a day and keep it in check," said Furman.

The company that makes idelalisib has asked U.S. regulators to approve the drug within six months so it can be made available to people with chronic lymphocytic leukemia.  An article on idelalisib is published in The New England Journal of Medicine.  

You May Like

US Imposes Sanctions on Alleged Honduran Drug Gang

Treasury department alleges Los Valles group is responsible for smuggling tens of thousands of kilograms of cocaine into US each month More

At 91, Marvel Creator Stan Lee Continues to Expand his Universe

Company's chief emeritus hopes to interest new generation of children in superheroes of all shapes and sizes by publishing content across multiple media platforms More

Photogallery New Drug Protects Against Virus in Ebola Family

Study by researchers at University of Texas Medical Branch, Tekmira Pharmaceuticals is first looking at drug's effectiveness after onset of symptoms More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
African Media Tries to Educate Public About Ebolai
X
George Putic
August 20, 2014 8:57 PM
While the Ebola epidemic continues to claim lives in West Africa, information technology specialists, together with radio and TV reporters, are battling misinformation and prejudice about the disease - using social media to educate the public about the deadly virus. VOA’s George Putic has more.
Video

Video African Media Tries to Educate Public About Ebola

While the Ebola epidemic continues to claim lives in West Africa, information technology specialists, together with radio and TV reporters, are battling misinformation and prejudice about the disease - using social media to educate the public about the deadly virus. VOA’s George Putic has more.
Video

Video Ferguson Calls for Justice as Anger, Violence Grips Community

Violence, anger and frustration continue to grip the small St. Louis suburb of Ferguson, Missouri. Protests broke out after a white police officer fatally shot an unarmed black teenager on August 9. The case has sparked outrage around the nation and prompted the White House to send U.S. Attorney Eric Holder to the small community of just over 20,000 people. VOA’s Mary Alice Salinas has more from Ferguson.
Video

Video Beheading Of US Journalist Breeds Outrage

U.S. and British authorities have launched an investigation into an Islamic State video showing the beheading of kidnapped American journalist James Foley by a militant with a British accent. The extremist group, which posted the video on the Internet Tuesday, said the murder was revenge for U.S. airstrikes on militant positions in Iraq - and has threatened to execute another American journalist it is holding. Henry Ridgwell has more from London.
Video

Video Family Robots - The Next Big Thing?

Robots that can help us with daily chores like cooking and cleaning are a long way off, but automatons that serve as family companions may be much closer. Researchers in the United States, France, Japan and other countries are racing to build robots that can entertain and perform some simpler tasks for us. VOA’s George Putic reports.
Video

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As the Ukrainian military reclaims control of eastern cities from pro-Russian separatists, residents are getting a chance to rebuild their lives. VOA's Gabe Joselow reports from the town of Kramatorsk in Donetsk province, where a sense of fear is still in the air, and distrust of the government in Kyiv still runs deep.
Video

Video Five Patients Given Experimental Ebola Drug Said to Be Improving

The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video China Targets Overseas Assets of Corrupt Officials

As China presses forward with its anti-graft effort, authorities are targeting corrupt officials who have sent family members and assets overseas. The efforts have stirred up a debate at home on exactly how many officials take that route and how likely it is they will be caught. Rebecca Valli has this report.
Video

Video Leading The Fight Against Islamic State, Kurds Question Iraqi Future

Western countries including the United States have begun arming the Kurdish Peshmerga forces in northern Iraq to aid their battle against extremist Sunni militants from the Islamic State. But there are concerns that a heavily-armed Kurdistan Regional Government, or KRG, might seek to declare independence and cause the break-up of the Iraqi state. As Henry Ridgwell reports from London, the KRG says it will only seek greater autonomy from Baghdad.
Video

Video In Rural Kenya, Pressure Builds Against Female Circumcision

In some Kenyan communities, female genital mutilation remains a rite of passage. But activists are pushing back, with education for girls and with threats of punishment those who perform the circumcision. Mohammed Yusuf looks at the practice in the rural eastern community of Tharaka-Nithi.

AppleAndroid